Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis

Xu, C; Su, YM; Paccaly, A; Kanamaluru, V

Xu, C (reprint author), Sanofi Genzyme, 55 Corp Dr, Bridgewater, NJ 08807 USA.

CLINICAL PHARMACOKINETICS, 2019; 58 (11): 1455

Abstract

Background and Objective Sarilumab binds to the interleukin-6 receptor with high affinity, inhibiting cis and trans signaling by interleukin-6. Sarilu......

Full Text Link